Injection Site Erythema in a Patient on Therapeutic Anticoagulation with Low Molecular Weight Heparin after Mechanical Aortic Valve Replacement: A Rare Presentation of Heparin- and Protamine-Induced Thrombocytopenia
Previous exposition to heparin and protamine in patients undergoing cardiopulmonary bypass and postoperative therapeutic anticoagulation with LMWH may lead to the development of heparin-induced thrombocytopenia (HIT) and/or protamine-induced thrombocytopenia (PIT). This case deals with a rare clinic...
Main Authors: | Caroline Holaubek, Paul Simon, Sabine Eichinger-Hasenauer, Franz Gremmel, Barbara Steinlechner |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Case Reports in Immunology |
Online Access: | http://dx.doi.org/10.1155/2020/4503598 |
Similar Items
-
Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
by: Abdul Mannan Khan Minhas, et al.
Published: (2017-01-01) -
Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
by: Barbara Steinlechner, et al.
Published: (2021-01-01) -
The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents
by: Joanna Miklosz, et al.
Published: (2019-09-01) -
HEPARIN INDUCED THROMBOCYTOPENIA
by: Matija Kozak, et al.
Published: (2008-03-01) -
Heparin-induced thrombocytopenia
by: Shaikh Nissar
Published: (2011-01-01)